This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Gefitinib Versus Vinorelbine Plus Cisplatin as Adj...
Journal

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Read time: 1 mins
Published:28th Feb 2021
Author: Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Wei YC et al.
Availability: Free full text
Ref.:J Clin Oncol. 2021 Mar 1;39(7):713-722.
DOI:10.1200/JCO.20.01820
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest